INTRODUCTION
In order to understand regulatory processes in detail it is crucial to investigate and analyse the mechanisms by which sequence-specific DNA-binding proteins recognize and interact with their DNA target sites. For some of these proteins one important step forward has been the elucidation of their three-dimensional structure by X-ray crystallography: for example, the cyclic AMP receptor protein (CRP) from E. coli (McKay & Steitz, 1981) ; the cro repressor protein from bacteriophage A (Anderson et al., 1981) and the N-terminal fragment of the cI repressor (Pabo & Lewis, 1982) . Structure and sequence comparisons have suggested that a common helix-turnhelix motif may play the most important role in sequencespecific recognition, and several models for this interaction have been put forward Sauer et al., 1982; Anderson et al., 1982; Steitz et al., 1982) . The model for the cro repressor was tested using mutant proteins engineered in a synthetic cro gene. DNA-binding properties of these mutants were determined, confirming the proposed contacts between cro repressor and operator DNA (Eisenbeis et al., 1985) . However, the ultimate goal of obtaining structural data on protein-DNA complexes has not been achieved in the above systems to date.
One prerequisite for any structural investigations of protein-DNA complexes is the availability of sufficient amounts ofboth components. DNA fragments containing specific sites for CRP have been synthesized in large quantity and their solution structures investigated by n.m.r. spectroscopy (Gronenborn et al., 1984; Clore & Gronenborn, 1984a ,b, 1985 . In the present paper we describe the construction of plasmids encoding the crp structural gene either under the control of the tac promotor (Amann et al., 1983) or the bacteriophage A promotor PL (Remaut et al., 1981) . These plasmids in the appropriate host strains allow after induction the overproduction of CRP up (Amann et al., 1983) , and E. coli K-12 AH I Atrp [rpsL, lacZam, Abio-uvrB, AtrpEA2 (ANam7, Nam53,cI857,AH1)] (Bernard et al., 1979) A. M. Gronenborn and G. M. Clore Protein gels and immune blots SDS/polyacrylamide gels for protein separation were prepared and used according to Laemmli (1970) . Electrophoretic transfer from the protein gel on to nitrocellulose was carried out for I h at 12 V/cm in 24.8 mM-Tris/0. 19 M-glycine containing 20% (v/v) methanol at 0 'C. Immunodetection was carried out as follows. The nitrocellulose filter, carrying either the dots of cell lysate or the blotted gel, was washed thoroughly in 10 mM-Tris/0.900 NaC1/0.05% Tween 20 (polyoxyethylenesorbitan monolaurate) and overlayed with the anti-CRP serum at a 1: 20 or 1: 50 dilution overnight in a humid chamber. After extensive washing the filters were subsequently overlayed for 3-4 h with 125I-labelled goat anti-rabbit antibodies (total globulin fraction) at approx. 5 x 105 c.p.m./ml in 10 mM-Tris/0.9% NaCI/0.05 % Tween20/4% bovine serum albumin/0.2% NaN3. These labelled goat anti-rabbit antibodies had been cleaned up by preabsorption onto nitrocellulose filters previously treated with rabbit serum. This treatment removes any non-specific interaction of the labelled goat anti-rabbit antibodies with the anti-CRP serum. Since there is a large excess ofgoat antibodies over bound rabbit serum, the goat antibodies can be used for several further experiments. The filters were washed again thoroughly in the wash buffer, air dried and autoradiographed.
DNA sequence analysis
The DNA sequence of the /crp construct was determined by the method of Sanger et al. (1977) using a-35S-labelled ATP after shuttling the insert from pUC9 to M13mp9.
CRP assay
The amount of CRP present in crude cell extracts was assayed using the cyclic AMP binding assay as described by Pastan et al. (1984) . Cell extracts were prepared as follows. Cultures (10 ml) grown to an A;60 of 1 were centrifuged, the cells washed with 5 ml of0.1 M-Tris/HCl, pH 8, centrifuged and resuspended in 1 ml of 0.1 MTris/HCl, pH 8, containing 10 mM-EDTA. Lysosyme (50 S1 of 4 mg/ml) was then added and the mixture left on ice for 10 min. After this lysis step the mixture was centrifuged and the resulting supernatant used for the cyclic AMP binding assay. Over production of cyclic AMP receptor protein
RESULTS
Overproduction of CRP Fig. 1 outlines the organization of the crp gene within the plasmids pCAPl and pCAP2 which are both derivatives ofpBScrp2 (Cossart & Gicquel-Sanzey, 1982) , as well as in those plasmids used for the overproduction of CRP. pCAP1 contains the same BamHl fragment encompassing the crp gene which was originally inserted into pBScrp2 but now inserted in opposite orientation. Since it has been shown that CRP can act in an autoregulatory fashion by binding to a site near its promoter (Aiba, 1983; Cossart & Gicquel-Sanzey, 1983) , we decided to eliminate the crp promoter from all our constructs. This is easily achieved, since the promoter is located about 170 bp upstream of the ATG start of the coding sequence and the CRP binding site lies directly downstream of the RNA polymerase site (Aiba, 1983) .
Thus one can separate these transcriptional control elements from the coding region using appropriate restriction fragments. A HindIll site fortuitously lies between the promoter region and the ribosome binding site. We therefore used the Hindlll insert from pCAP2 for insertion into both expression vectors.
The first construction uses the plasmid ptacl2H which contains the tac promoter, a fusion promoter derived from the -35 trp promoter region and the -10 lac UV5 promotor region (Amann et al., 1983) followed by a HindIll cloning site. The HindIlI fragment cut from pCAP2 was inserted into this cloning site and recombinant plasmids containing the gene in both orientations were found after transformation in an E. coli strain overproducing the lac repressor (see Fig. 1 ). CRP production was monitored by a cyclic AMP binding assay (Pastan et al., 1974) . Upon induction with IPTG, a 15-fold increase in CRP activity with respect to a wild type strain was found for the strain carrying the plasmid pCAPl 1 which contains the crp gene under transcriptional control of the tac promotor.
The second construction uses the plasmid pPLc28 which contains the leftward A promotor PL and allows expression to be controlled by the temperature sensitive cI 857 repressor (Remaut et al., 1981 Vol. 236 645 (b) promoter was inserted into the HindIII cloning site and, after transformation of E.-c-1i K-12 AHIAtrp, recombinant plasmids with the gene in both orientations were found. The plasmid pPLcCRP1 (Fig. 1) , which contains the crp gene under APL control, can be induced by a temperature shift from 29°C to 42°C in mid-exponential phase, thereby switching CRP production on up to levels approx. 100 times that of a strain harbouring the same plasmid in a non-induced state. Construction of synthetic gene for the C-terminal DNA-binding domain of CRP Fig. 2 outlines the scheme used for the construction of a synthetic gene coding for the C-terminal DNA binding domain of CRP. The idea for the construction of such a gene was born from the requirement of a small size protein in order to determine the structure of a protein-DNA complex by n.m.r. methods. As far as can be judged from the X-ray structure the C-terminal domain is folded independently from the rest of the protein being connected to the N-terminal domain via a hinge region. This hinge region is formed by amino acids 135-138. The nucleotide sequence for Leu-137 and Asp-138 reads CTCGAC (Cossart & Gicquel-Sanzey, 1982; Aiba et al., 1982) . Thus it contains a cutting site for TaqI, which should therefore allow the separation ofthe DNA sequence coding for the C-terminal domain from the rest of the coding sequence (Fig. 2a) . We decided to construct a fusion gene by joining this C-terminal part of the sequence to the very first stretch of the coding sequence. This approach was chosen since there is a second TaqI site in the crp coding sequence, namely at the position coding for amino acids Leu-1 1 and Glu-12 (Fig. 2b) . Both cutting sites occur at equivalent positions in the reading frame. Thus, upon ligation the reading frame should be left intact in such a manner that the nucleotide sequence now encodes a protein which consists of the first 10 amino acids of CRP followed by the C-terminal domain with Leu-11 being replaced by Leu-137.
The construction was carried out in the following way. sequence determined by dideoxy-sequencing (Sanger et al., 1977) . Fig. 2(c) (Fig. 3) . Subcloning the 360 bp HindIII/EcoRV fragment into HindIII/Smal-digested pUC9 (Viera & Messing, 1982) resulted in two different clones containing the insert in the correct orientation (i.e. behind the lac promoter), namely pUC9-,/CRPI in which the EcoRV site is fused to the RsaI site, and pUC9-,BCRP2 which contains the insert flanked by HindIII sites . (Fig. 3) . This HindIII insert, excised from pUC9-flCRP2, was shuttled across to HindlIl-cut pPLc28, yielding recombinant plasmids with the insert in either orientation. The plasmid withthecorrect orientation (i.e. containing the crp gene behind the APL promotor), known as pPLc,BCRP2, was also used in the expression experiments. Fig. 4 shows a polyacrylamide gel with cell extracts from E. coli AHlAtrp harbouring pPLc/JCRP1 and pPLcCRPI taken at different time points before and after induction. All be found, we used antibodies directed against CRP to probe for such a ,/CRP protein. The underlying basis for this experiment is that a variety of different antibodies recognizing different parts of the protein will be present in a polyclonal serum. Thus, if the isolated C-terminal domain of CRP is folded in the same way as it is in the intact protein, some ofthe antibodies in the serum should be able to recognize the new /JCRP protein. Fig. 5 (Fig. 6a) . Here again anti-CRP antibodies were used for detection. As can be clearly observed (Fig. 6b) (Remaut et al., 1981) has allowed CRP production up to levels of approx. 100 times that of an E. coli wild type strain. Using the expression vector pPLcCRP1 it is very easy to produce and purify CRP in large quantities. The APL promotor system seems a somewhat better system than the tac promotor system in this case for two reasons. First, repression of the tac promotor in the absence of IPTG is not complete, at least not for our host strain which carries the IQ gene on the F'. Second, and most importantly, the level of CRP production achieved with the APL promotor is a factor of 10 higher than that with the tac promotor. Furthermore, heat induction is cheaper and easier than IPTG addition. One point worth mentioning is the fact that these extremely high levels of CRP do not interfere with cell growth and viability. Growth curves for the induced pPLcCRPI harbouring strain are almost indistinguishable from those of a strain harbouring only pPLc28 and cell growth continues to an A660 value of around 4 in both cases.
Protein design by genetic engineering seems to be the method of choice to study structure-activity relationships. Using oligonucleotide-directed mutagenesis a variety of systems are presently under investigation, such as the enzymes tyrosyl-tRNA synthetase (Winter et al., 1982; Way et al., 1983) , dihydrofolate reductase (Villafranca et al., 1983) and triosephosphate isomerase (Petsko et al., 1984) . DNA-binding proteins such as the cro repressor have also been investigated (Eisenbeis et al., 1985) . We have constructed at the DNA level a novel protein which contains the DNA binding domain of CRP. This protein, /JCRP, however, cannot fulfill the role of CRP in vivo, namely transcriptional enhancement of the lac gene as judged on lac indicator plates. This may be due to several reasons. First, flCRP might not interact with the specific CRP site on the DNA in the same manner as the CRP -cyclic AMP complex does. Second, since flCRP is a monomer, it is likely that its DNAbinding constant is much lower than that of the dimeric CRP so that a much higher protein concentration may be required to achieve the transcriptional effect. Or third, it might not be a DNA-binding protein at all. We think the latter highly unlikely, since all the structural features commonly found in DNA-binding repressors are preserved. Experiments are now necessary to test the DNA-binding properties of /JCRP and to attempt its purification for structural studies. This should open the way to study contact points between the DNA-binding helix in /JCRP and DNA fragments by n.m.r. spectroscopy.
